Slide 1
Our Vision
Restore infinite mobility to patients suffering from sports injuries.
arrow
Slide 2
Artificial Ligament LARSTM
A clinically proven product range broadening your treatment options.
arrow
Slide 2
Celebrating 30 Years
We have been helping surgeons to restore their patients’ mobility for 3 decades.
arrow
logo-movmedix-presentation
Our company was founded 30 years ago, in 1992 by Dr Jacques-Philippe Laboureau, the inventor of the intra-articular free fibre artificial ligament, under the name of L.A.R.S. (Laboratoire d’Application et de Recherche Scientifique). Our company has been leading the artificial ligaments market for years, and continues to be at the forefront of innovation in this field.

Today under the new name movmedix®, we are evolving to become a global player in the Sports Medicine market; the strong heritage of our LARSTM (Ligament Advanced Reinforcement System) product range offers a solid base for developing innovative and disruptive solutions. We have been looking at cutting-edge science and technology for better serving surgeons and patients.

Our transformation is still on going, and our website is evolving in the next months, so that we can better serve you.

idea

Filed patents
patient

Patients
countries

Countries/Regions 

publications

Scientific publications

Synthetic ligament
LARS™, the reference

ligament
logo-lars
LARSTM ligaments are made of PET (polyethylene terephthalate), have a unique patented design, and are cleaned with a high performing process, allowing movmedix to offer the patients, including the most active ones and athletes, a high-quality product. More than 60 scientific publications show good clinical short-, medium- and long-term results. Short term clinical outcomes of LARSTM ligaments are comparable with autografts.
ligament
logo-lars

Movmedix: 30 years of knowhow

Company foundation

The company is founded by Dr Jacques-Philippe Laboureau under the name of L.A.R.S., introducing the 3rd generation of artificial ligaments LARS™

1992

1997

CE clearance of LARS

LARS obtains the CE marking and is commercially launched in most European countries

Sales expansion and 1st surgery in China

The company expands outside Europe and China, entering some of the major international markets such as Australia, Canada or Taiwan

2003-16

2016

Biomimetic ligament

The company starts the development of a 4th generation of artificial ligament in collaboration with Paris XIII University

Bioresorbable and biomimetic ligament

The company starts the development of the 5th generation of artificial ligaments with the financial support of BPI

2017

2021

Movmedix

L.A.R.S. is acquired by Huaxing HC fund and becomes movmedix

Clinical investigation

The 4th generation of bioactive ligament is implanted in Italy as part of a clinical investigation

2022

1992 - Company foundation

The company is founded by Dr Jacques-Philippe Laboureau under the name of L.A.R.S., introducing the 3rd generation of artificial ligaments LARS™

1997 - 1st CE clearance

LARS obtains the CE marking and is commercially launched in most European countries

2003-2016 - Sales expansion 1st surgery in china

The company expands outside Europe and China, entering some of the major international markets such as Australia, Canada or Taiwan

2016 - Biomimetic ligament

The company starts the development of a 4th generation of artificial ligament in collaboration with Paris XIII University

2017 - Bioresorbable & Biomimetic ligament

The company starts the development of the 5th generation of artificial ligaments with the financial support of BPI

2021 - Movmedix

L.A.R.S. is acquired by Huaxing HC fund and becomes movmedix

2022 - Clinical investigation

The 4th generation of bioactive ligament is implanted in Italy as part of a clinical investigation